1. Reduced Expression ofCAMTA1Correlates with Adverse Outcome in Neuroblastoma Patients
   Kai-Oliver Henrich et al, 2006, Clinical Cancer Research CrossRef
2. MicroRNA‐34a: A Key Regulator in the Hallmarks of Renal Cell Carcinoma
   Eman A. Toraih et al, 2017, Oxidative Medicine and Cellular Longevity CrossRef
3. Evaluation of the Antitumor and Radiosynthetizing Activity of a Novel Quinoline Sulfonamide Derivative (PIQSA) as a Histone Deacetylase Inhibitor
   Eman Noaman et al, 2011, Journal of Cancer Therapy CrossRef